Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care Population
Use of Managed Care Claims Data in the Risk Assessment of Venous Thromboembolism in Outpatients
Outpatient Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin: An Economic Evaluation
Anti-inflammatory Therapy Reduces Total Costs of Asthma Care Compared with Bronchodilation: The Asthma Outcomes Registry
